1. Continuous oxygen monitoring to enhance ex-vivo organ machine perfusion and reconstructive surgery.
- Author
-
Berkane Y, Cascales JP, Roussakis E, Lellouch AG, Slade J, Bertheuil N, Randolph MA, Cetrulo CL Jr, Evans CL, and Uygun K
- Subjects
- Humans, Animals, Monitoring, Physiologic methods, Monitoring, Physiologic instrumentation, Equipment Design, Surgical Flaps, Swine, Oxygen metabolism, Perfusion, Biosensing Techniques instrumentation, Biosensing Techniques methods, Plastic Surgery Procedures
- Abstract
Continuous oxygenation monitoring of machine-perfused organs or transposed autologous tissue is not currently implemented in clinical practice. Oxygenation is a critical parameter that could be used to verify tissue viability and guide corrective interventions, such as perfusion machine parameters or surgical revision. This work presents an innovative technology based on oxygen-sensitive, phosphorescent metalloporphyrin allowing continuous and non-invasive oxygen monitoring of ex-vivo perfused vascularized fasciocutaneous flaps. The method comprises a small, low-energy optical transcutaneous oxygen sensor applied on the flap's skin paddle as well as oxygen sensing devices placed into the tubing. An intermittent perfusion setting was designed to study the response time and accuracy of this technology over a total of 54 perfusion cycles. We further evaluated correlation between the continuous oxygen measurements and gold-standard perfusion viability metrics such as vascular resistance, with good agreement suggesting potential to monitor graft viability at high frequency, opening the possibility to employ feedback control algorithms in the future. This proof-of-concept study opens a range of research and clinical applications in reconstructive surgery and transplantation at a time when perfusion machines undergo rapid clinical adoption with potential to improve outcomes across a variety of surgical procedures and dramatically increase access to transplant medicine., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Korkut Uygun reports a relationship with Sylvatica Biotech Inc that includes: board membership and equity or stocks. Korkut Uygun, Conor L. Evans, Emmanuel Rousakis, Juan Pedro Cascales, Yanis Berkane, and Alexandre G. Lellouch have patent #63/377,519, filed September 28, 2023 pending to Massachusetts General Hospital. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF